Silverback Therapeutics, Inc.
Benzazepine compounds, conjugates, and uses thereof
Last updated:
Abstract:
Benzazepine compounds, conjugates, and pharmaceutical compositions for use in the treatment of disease, such as cancer, are disclosed herein. The disclosed benzazepine compounds are useful, among other things, in the treating of cancer and modulating TLR8. Additionally, benzazepine compounds incorporated into a conjugate with an antibody construct are described herein.
Status:
Grant
Type:
Utility
Filling date:
7 May 2018
Issue date:
31 Dec 2019